Kairos Pharma, Ltd. (KAPA) Stock Ticker
Market factors today
Unlock the full KAPA picture
About Kairos Pharma, Ltd.
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, Inc., the enterprise officially adopted its current identity as Kairos Pharma, Ltd. in July 2016. The company's operations are headquartered in Los Angeles, California.
KAPA stock facts
| Ticker symbol | KAPA |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $5.1M |
| CEO | John S. Yu |
| Employees | 4 |
| Headquarters | Los Angeles, CA, US |
| IPO date | 2024-09-16 |
| Website | kairospharma.com |
What you can see for KAPA on Tickr
Live KAPA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KAPA report.
Rankings
FAQ
What is the ticker symbol for Kairos Pharma, Ltd.?
The ticker symbol for Kairos Pharma, Ltd. is KAPA, listed on the New York Stock Exchange Arca.
What is KAPA?
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13,…